Stoke Therapeutics Inc
NASDAQ:STOK
Stoke Therapeutics Inc
NASDAQ:STOK
Price:
33.125
USD
6.92%
Market Closed
Market Cap:
$1.9B
Balance Sheet
Balance Sheet Decomposition
Stoke Therapeutics Inc
Stoke Therapeutics Inc
Balance Sheet Decomposition is not available for
Stoke Therapeutics Inc
Stoke Therapeutics Inc
Balance Sheet
Stoke Therapeutics Inc
Stoke Therapeutics Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
2
|
105
|
223
|
287
|
145
|
114
|
191
|
128
|
|
| Cash Equivalents |
2
|
105
|
223
|
287
|
145
|
114
|
191
|
128
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
75
|
116
|
10
|
89
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Other Current Assets |
0
|
1
|
3
|
7
|
9
|
14
|
14
|
15
|
|
| Total Current Assets |
2
|
106
|
226
|
294
|
229
|
244
|
215
|
233
|
|
| PP&E Net |
1
|
1
|
3
|
4
|
9
|
11
|
12
|
8
|
|
| PP&E Gross |
1
|
1
|
3
|
4
|
9
|
11
|
12
|
8
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
3
|
4
|
7
|
9
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Assets |
2
N/A
|
108
+4 379%
|
229
+113%
|
298
+30%
|
239
-20%
|
256
+7%
|
228
-11%
|
272
+19%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
1
|
1
|
2
|
2
|
1
|
2
|
2
|
|
| Accrued Liabilities |
1
|
1
|
3
|
9
|
14
|
15
|
13
|
18
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
3
|
0
|
0
|
1
|
1
|
15
|
16
|
20
|
|
| Total Current Liabilities |
4
|
3
|
4
|
11
|
17
|
31
|
31
|
40
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
4
|
40
|
38
|
2
|
|
| Total Liabilities |
4
N/A
|
3
-32%
|
4
+72%
|
12
+174%
|
21
+79%
|
71
+237%
|
69
-3%
|
43
-38%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
13
|
26
|
58
|
110
|
196
|
297
|
402
|
491
|
|
| Additional Paid In Capital |
12
|
131
|
283
|
396
|
414
|
483
|
561
|
720
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
1
N/A
|
105
N/A
|
224
+114%
|
286
+27%
|
218
-24%
|
185
-15%
|
160
-14%
|
229
+44%
|
|
| Total Liabilities & Equity |
2
N/A
|
108
+4 379%
|
229
+113%
|
298
+30%
|
239
-20%
|
256
+7%
|
228
-11%
|
272
+19%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
30
|
30
|
33
|
37
|
37
|
39
|
46
|
54
|
|
Switch to:
Switch to:
See Also
Discover More
